10 Dirt Cheap Stocks To Invest In Now

3. Merck & Co., Inc. (NYSE:MRK)

Forward P/E Ratio: 8.84

Earnings Growth This Year: 17.09%

Number of Hedge Fund Holders: 91

Merck & Co., Inc. (NYSE:MRK) is another international pharmaceutical company that operates through two main segments namely Pharmaceuticals and Animal Health. On April 8th, Goldman Sachs analyst Asad Haider maintained a Buy rating on the stock.

The analyst noted that the market is overly pessimistic about Merck & Co., Inc. (NYSE:MRK) and its product pipeline value. He noted that the Animal Health segment of the company generates substantial revenue while showing growth potential. Haider believes that the segment is also highly undervalued by the market.

In addition, Keytruda is one of the key drugs by the company. The sales for Keytruda in 2024 reached $29.5 billion, reflecting an 18% increase year-over-year. Moreover, the overall global sales improved by 7% year-over-year during the fourth quarter alone to reach $15.6 billion. Merck & Co., Inc. (NYSE:MRK) is one of the dirt-cheap stocks to invest in now.